Introduction
The healthcare sector in India is witnessing a change with the advancement of technology. The use of medical devices is not limited to wards and laboratories anymore. Smart insulin pumps, fitness trackers, heart rate monitors, intelligent diagnostic applications, image processing systems, and patient monitoring applications are some of the many innovations that form part of the healthcare system in today’s world.
However, the digital revolution also brought about a change in how medical devices function. The technology is not limited to just being used for diagnostic or therapeutic purposes; rather, it now operates as a constant collector and processor of personal data of data principals or patients in the instant case. Each heartbeat measured using a smartwatch, each blood glucose measurement conducted via a connected sensor, or image analysed using artificial intelligence adds to the ever-growing issues of protection and security of personal data. It is therefore pertinent that the healthcare industry complies with the Digital Personal Data Protection Act, 2023 (“DPDP Act”) thoroughly.
Medical Devices and Data Processing
In today’s techno-advanced era, the healthcare sector is using medical devices for various functions in order to cut down the cost and focus more on smoother delivery of healthcare services. However, medical devices use an abundant amount of information as well as personal data. Although it serves as a better healthcare delivery service by conducting an easier diagnosis, such data processing may bring more risks to the protection and security of personal data of patients.
In case the device fails to work properly, the personal information of any patient, medical records, and diagnosis can be exposed. With the development of the IoT, AI, and cloud computing technologies, manufacturers of medical devices should consider data protection a crucial element of the product development process.
Recently, the world’s largest medical device manufacturer, Medtronic, suffered a huge cyberattack that compromised the personal data of millions and resulted in stolen records of personal as well as sensitive personal data of individuals. Another such instance calls for the cyberattack that occurred in the IT systems of Michigan-based medical device manufacturer Stryker Corporation. The attack caused devices to stop working for employees, interfered with the production of medical devices, and affected the LIFENET emergency communication network for healthcare professionals.
Privacy By Design
Some of the ways that medical devices can comply with the provisions of the DPDP Act include using the concept of privacy by design. Rather than trying to deal with the issue of privacy when the product is already on the market, manufacturers should integrate privacy into the design process.
Medical device manufacturers should rather resort to risk identification and analysis and ensure management of cybersecurity risks throughout the lifecycle of the medical devices. In this way, privacy will be enhanced while still enabling effective delivery of health services. Medical devices should also be programmed in such a way that they collect only the information required for the purpose of their operation. There is no need to collect more personal information just because the device can store large amounts of information.
Additionally, manufacturers and the healthcare industry should implement risk assessment by complying with the provisions of the DPDP Act and DPDP Rules, such as involving heavy encryption of the personal data, secure authentication, conducting audits, and monitoring the effectiveness of the medical devices along with backup mechanisms.
Prior Risk Assessment and Security Implementation
MedTech needs to adopt security and privacy protections for all stages of its product lifecycle. Such security measures include encryption, authentication, access management, secure updates, logging of activities, and vulnerability assessments to ensure that sensitive patient information is not accessed without proper authorization and protected against any cyber-attacks. In addition, companies need to conduct a DPIA prior to using new technologies such as AI applications, remote patient monitoring tools, or cloud computing platforms to determine their privacy impact. It is also important to establish an efficient governance framework for cross-border transfer of personal information, accountability, security checks, and audits.
Additionally, the regulatory environment is also changing to match the pace of healthcare technology that relies on software. The Central Drugs Standard Control Organization (CDSCO) has recently introduced draft guidelines titled Guidance Document on Medical Device Software for the classification, development, approval, and post-market monitoring of medical device software. However, these are mere draft guidelines and have not yet been implemented.
Moreover, manufacturers and the healthcare industry shall abide by the ISO guidelines such as ISO 13485, which takes into consideration the quality management for medical devices, IEC 62304, which undertakes the procedure for maintenance of medical devices throughout their product lifecycle; and ISO 14971, which provides for risk management for medical devices.
AMLEGALS Remarks
The development of medical devices has gone from simple instruments to advanced technology solutions, the collection, processing, and usage of patient data have changed dramatically. Even though these developments increase the quality of care, they bring numerous privacy and cybersecurity risks. It is imperative for the healthcare industry and medical device manufacturers to abide by the DPDP Act and DPDP Rules in order to protect the personal data of the patients. Additionally, it is pertinent to adhere to the ISO guidelines and undertake risk assessment and management throughout the product lifecycle of the medical devices. Since the CDSCO guidelines have not been implemented yet, the final regulatory framework and its practical implications for the MedTech industry remain to be seen.
For any queries or feedback, feel free to connect with mridusha.guha@amlegals.com or Khilansha.mukhija@amlegals.com
